(Reuters) - Biogen and Ionis Pharmaceuticals said on Thursday they will terminate the development of their treatment for amyotrophic lateral sclerosis (ALS) based on results from an early-stage study. (Reporting by Christy Santhosh; Editing by Son.
Merck treatment for a type of uterus cancer fails trial
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Masimo says prepared to provide one board seat to activist investor Politan
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Merck s endometrial cancer therapy fails trial
saltwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltwire.com Daily Mail and Mail on Sunday newspapers.